SEC Form 4 · accession 0001209191-19-002102
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles R Eyler
Officer — SEE REMARKS
Period of report
Jan 3, 2019
Accepted (ET)
Jan 4, 2019 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jan 3, 2019 | S | 1,210 | $20.67 | D | 32,757 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
Remarks
Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer